14507924|t|In vitro and in vivo interactions of homocysteine with human plasma transthyretin.
14507924|a|Hyperhomocysteinemia is an independent risk factor for cardiovascular disease and an emerging risk factor for cognitive dysfunction and Alzheimer's disease. Greater than 70% of the homocysteine in plasma is disulfide-bonded to protein cysteine residues. The identity and functional consequences of protein homocysteinylation are just now emerging. The amyloidogenic protein transthyretin (prealbumin), as we now report, undergoes homocysteinylation at its single cysteine residue (Cys10) both in vitro and in vivo. Thus, when human plasma or highly purified transthyretin was incubated with 35S-L-homocysteine followed by SDS-PAGE and PhosphorImaging, two bands corresponding to transthyretin dimer and tetramer were observed. Treatment of the labeled samples with beta-mercaptoethanol prior to SDS-PAGE removed the disulfide-bound homocysteine. Transthyretin-Cys10-S-S-homocysteine was then identified in vivo in plasma from normal donors, patients with end-stage renal disease, and homocystinurics by immunoprecipitation and high performance liquid chromatography/electrospray mass spectrometry. The ratios of transthyretin-Cys10-S-S-homocysteine and transthyretin-Cys10-S-S-sulfonate to that of unmodified transthyretin increased with increasing homocysteine plasma concentrations, whereas the ratio of transthyretin-Cys10-S-S-cysteine to that of unmodified transthyretin decreased. The hyperhomocysteinemic burden is thus reflected in the plasma levels of transthyretin-Cys10-S-S-homocysteine, which in turn may contribute to the pathological consequences of amyloid disease.
14507924	37	49	homocysteine	Chemical	MESH:D006710
14507924	55	60	human	Species	9606
14507924	68	81	transthyretin	Gene	7276
14507924	83	103	Hyperhomocysteinemia	Disease	MESH:D020138
14507924	138	160	cardiovascular disease	Disease	MESH:D002318
14507924	193	214	cognitive dysfunction	Disease	MESH:D003072
14507924	219	238	Alzheimer's disease	Disease	MESH:D000544
14507924	264	276	homocysteine	Chemical	MESH:D006710
14507924	290	299	disulfide	Chemical	MESH:D004220
14507924	318	326	cysteine	Chemical	MESH:D003545
14507924	457	470	transthyretin	Gene	7276
14507924	546	554	cysteine	Chemical	MESH:D003545
14507924	609	614	human	Species	9606
14507924	641	654	transthyretin	Gene	7276
14507924	674	692	35S-L-homocysteine	Chemical	-
14507924	705	708	SDS	Chemical	MESH:D012967
14507924	762	775	transthyretin	Gene	7276
14507924	848	868	beta-mercaptoethanol	Chemical	-
14507924	878	881	SDS	Chemical	MESH:D012967
14507924	899	908	disulfide	Chemical	MESH:D004220
14507924	915	927	homocysteine	Chemical	MESH:D006710
14507924	929	943	Transthyretin-	Gene	7276
14507924	943	965	Cys10-S-S-homocysteine	Chemical	-
14507924	1024	1032	patients	Species	9606
14507924	1038	1061	end-stage renal disease	Disease	MESH:D007676
14507924	1067	1082	homocystinurics	Disease	
14507924	1195	1208	transthyretin	Gene	7276
14507924	1209	1231	Cys10-S-S-homocysteine	Chemical	-
14507924	1236	1249	transthyretin	Gene	7276
14507924	1250	1269	Cys10-S-S-sulfonate	Chemical	-
14507924	1292	1305	transthyretin	Gene	7276
14507924	1332	1344	homocysteine	Chemical	MESH:D006710
14507924	1389	1402	transthyretin	Gene	7276
14507924	1403	1421	Cys10-S-S-cysteine	Chemical	-
14507924	1444	1457	transthyretin	Gene	7276
14507924	1473	1493	hyperhomocysteinemic	Disease	
14507924	1543	1556	transthyretin	Gene	7276
14507924	1557	1579	Cys10-S-S-homocysteine	Chemical	-
14507924	1646	1661	amyloid disease	Disease	MESH:C000718787
14507924	Association	MESH:C000718787	7276
14507924	Positive_Correlation	MESH:D006710	7276
14507924	Association	MESH:D004220	MESH:D006710
14507924	Association	MESH:D003545	MESH:D004220

